Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
03 May 2018Website:
http://www.inspiresleep.comNext earnings report:
06 February 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | 2 min agoDividend
Analysts recommendations
Institutional Ownership
INSP Latest News
BofA Securities has upgraded Inspire Medical Systems, Inc. INSP and says the company now falls in the profitable growth category.
MINNEAPOLIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.
MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.
Inspire Medical Systems, Inc. (NYSE:INSP ) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET Company Participants Ezgi Yagci – Vice President-Investor Relations Tim Herbert – President and Chief Executive Officer Rick Buchholz – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Danielle Antalffy – UBS Travis Steed – Bank of America Securities Adam Maeder – Piper Sandler David Rescott – Baird Michael Sarcone – Jefferies Richard Newitter – Truist Securities Larry Biegelsen – Wells Fargo Shagun Singh – RBC Kallum Titchmarsh – Morgan Stanley Jon Block – Stifel Anthony Petrone – Mizuho Americas Brett Fishbin – KeyBanc Capital Markets Chris Pasquale – Nephron Research Michael Polark – Wolfe Research Mike Kratky – Leerink Partners Suraj Kalia – Oppenheimer & Co Operator Good afternoon. My name is Dilem, and I'll be your conference operator today.
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.29 per share a year ago.
Inspire Reports Year-over-Year Revenue Growth of 33% and Earnings per Share of $0.60 in the Third Quarter Inspire Reports Year-over-Year Revenue Growth of 33% and Earnings per Share of $0.60 in the Third Quarter
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, 10x Genomics and Omnicell are expected to gain from the GenAI wave.
Inspire (INSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MINNEAPOLIS, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2024 after the close of trading on Monday, November 4. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
What type of business is Inspire Medical Systems?
Inspire Medical Systems, Inc. is a medical technology company specializing in the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea syndrome. The company was founded in 2005 and is headquartered in Arlington, Virginia, USA. The company is focused on developing and bringing to market minimally invasive solutions for treating patients with obstructive sleep apnea syndrome. The company has developed an innovative closed-loop solution that continuously monitors the patient's breathing pattern and provides gentle stimulation to the hypoglossal nerve to keep the airways open.
What sector is Inspire Medical Systems in?
Inspire Medical Systems is in the Healthcare sector
What industry is Inspire Medical Systems in?
Inspire Medical Systems is in the Medical Devices industry
What country is Inspire Medical Systems from?
Inspire Medical Systems is headquartered in United States
When did Inspire Medical Systems go public?
Inspire Medical Systems initial public offering (IPO) was on 03 May 2018
What is Inspire Medical Systems website?
https://www.inspiresleep.com
Is Inspire Medical Systems in the S&P 500?
No, Inspire Medical Systems is not included in the S&P 500 index
Is Inspire Medical Systems in the NASDAQ 100?
No, Inspire Medical Systems is not included in the NASDAQ 100 index
Is Inspire Medical Systems in the Dow Jones?
No, Inspire Medical Systems is not included in the Dow Jones index
When was Inspire Medical Systems the previous earnings report?
No data
When does Inspire Medical Systems earnings report?
The next expected earnings date for Inspire Medical Systems is 06 February 2025